Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders
NCT ID: NCT02993588
Last Updated: 2016-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
100 participants
INTERVENTIONAL
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males
NCT01793272
Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
NCT03129243
Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?
NCT02992665
Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility
NCT02469805
Effectiveness of Intracytoplasmic Sperm Injection and Laser Assisted Hatching on in Vitro Fertilization Outcomes of Patients With Different Causes of Infertility
NCT02026661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Melatonin
Melatonin 6 mg tablet once daily.
Melatonin
Melatonin 6 mg tablet once daily
Placebo
Placebo tablet once daily
Placebo
one tablet once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Melatonin
Melatonin 6 mg tablet once daily
Placebo
one tablet once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osama Saber Thabet Abdalmageed
Lecturer of OBGYN, Women Health Hospital, Assiut Univerisity
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Osama Abdalmageed, MD
Role: PRINCIPAL_INVESTIGATOR
Women health center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Osama Abdalmageed
Asyut, Asyut Governorate, Egypt
Osama Abdalmageed
Asyut, Non-US/Non-Canadian, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Osama Abdalmageed
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Fernando S, Rombauts L. Melatonin: shedding light on infertility?--A review of the recent literature. J Ovarian Res. 2014 Oct 21;7:98. doi: 10.1186/s13048-014-0098-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Melatonin RCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.